Skip to main content
. 2022 Apr 12;4(2):100196. doi: 10.1016/j.arrct.2022.100196

Table 2.

Changes in primary and secondary outcome measurements

Outcome Intervention
Control
Pretraining Post Training Pretraining Post Training Adjusted Difference (95% CI) at Post Training
Respiratory muscle strength
 PImax (cmH2O) −74±11 −93±19 −91±16 −98±13 −1 (−19 to 18)
 PEmax (cmH2O) 139±25 144±28 143±26 141±27 6 (-14 to 25)
Respiratory muscle endurance test
 Endurance breathing time (s) 209±79 741±282 269±133 321±236 472 (217 to 728)
 Total work (J) 103±61 560±403 206±131 326±157 336 (24 to 648)
 Average power (W) 2.0±1.2 5.9±2.5 4.5±2.2 6.9±1.9 1.4 (−1.2 to 4.0)
 Average volume (L) 1.8±0.7 2.6±0.7 2.1±0.6 2.5±0.4 0.3 (−0.3 to 0.8)
CWR cycle ergometer exercise test
 Work rate (W) 99±23 98±23 94±24 94±24
 Reason stopping (% dyspnea) 57±17 53±19 41±26 48±15 −10 (−32 to 12)
Isotime
 Exercise capacity (s) 400±218 367±272
 Dyspnea isotime (Borg units) 5.8±2.1 3.3±1.9 6.0±3.3 5.2±2.8 −1.8 (−3.7 to 0.13)
 Leg discomfort (Borg units) 5.4±1.7 4.0±1.9 7.6±2.6 7.6±1.8 −1.3 (−3.2 to 0.6)
 Heart rate (beats/min) 150±21 139±22 127±28 134±26 −15 (−27 to −3)
 VE (L/min) 57.2±23.2 47.7±19.0 55.7±16.0 51.7±13.6 −5.1 (−12.7 to 2.5)
 VT (L) 1.86±0.52 1.73±0.52 1.69±0.22 1.65±0.24 −0.05 (−0.30 to 0.19)
 RR (breaths/min) 31±6 28±6 34±10 32±10 −2 (−7 to 2)
 V̇o2 (L/min) 1.71±0.46 1.48±0.44 1.56±0.38 1.49±0.30 −0.1 (−0.3 to 0.0)
 VCo2 (L/min) 1.95±0.62 1.55±0.51 1.68±0.41 1.64±0.34 −0.27 (−0.55 to 0.00)
 RQ 1.13±0.16 1.03±0.15 1.08±0.08 1.11±0.10 −0.11 (−0.21 to −0.00)
 IC (L) 2.43±0.35 2.57±0.47 2.47±0.29 2.49±0.36 0.12 (−0.18 to 0.42)
Peak exercise
 Exercise time (s) 467±218 933±267 460±272 500±294 428 (223 to 633)
 Dyspnea (Borg units) 6.9±2.3 6.0±2.2 7.6±3.2 6.9±2.6 −0.5 (−2.6 to 1.5)
 Leg discomfort (Borg units) 6.4±2.4 6.2±2.7 8.8±1.6 7.6±1.8 −1.1 (−3.8 to 1.7)
 Heart rate (beats/min) 155±16 145±29 134±26 139±24 −16 (−31 to 0)
 VE (L/min) 58.4±22.2 57.0±17.3 59.0±12.6 57.6±10.2 −0.2 (−10.6 to 10.1)
 V̇o2 (L/min) 1.76±0.44 1.64±0.32 1.64±0.33 1.59±0.26 −0.00 (−0.25 to 0.24)
Symptoms of dyspnea
 TDI total score (−9 to +9) 7.0±1.2 4.1±3.0 2.9 (0.5 to 5.3)
 MDP (A1, 0 to 10) 6.7±1.9 4.8±3.5 6.4±3.1 6.6±2.6 −2.0 (−4.3 to 0.4)
 mMRC (0 to 4) 0.8±0.4 0.2±0.4 1.0±0.7 0.7±0.7 −0.4 (−0.8 to 0.1)
Functional exercise capacity
 6MWD (m), dyspnea post
 6MWD, leg discomfort post
 6MWD (N), handgrip strength
557±87
2.9±1.4
2.7±1.7
255±53
584±71
2.4±1.6
545±101
3.3±2.4
580±85
2.2±0.9
−5 (−45 to 35)
0.2 (−1.2 to 1.6)
1.1 (−1.1 to 3.5)
4 (−15 to 23)
2.6±1.6
255±50
4.8±2.9
248±29
3.6±2.2
256±34

NOTE. Data are presented as mean ± SD.

Abbreviations: CWR, constant work rate; IC, inspiratory capacity; isotime, the time of the post measurement equal to the end of time of the premeasurement; MDP, multidimensional dyspnea profile; mMRC, modified medical research council scale; peak exercise, averaged last 30 s of loaded cycling; PEmax, maximal expiratory pressure; RQ, respiratory quotient; RR, respiratory rate; 6MWD, 6-minute walking distance; 10-point Borg, modified Borg Dyspnea Scale (0-10); VCo2, carbon dioxide production; VE, ventilation; V̇o2, oxygen consumption; VT, tidal volume.

P<.05, within-group differences pre- vs post intervention by paired t test or Wilcoxon test.

P<.05, between-group differences intervention vs control by analysis of covariance.